Opus Genetics, Inc. (IRD) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of Opus Genetics, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Opus Genetics, Inc. logo
IRD
Opus Genetics, Inc.
$362M
$4.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
YD Bio Limited Ordinary Shares logo
YDES
YD Bio Limited Ordinary Shares
$436M
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — IRD vs YDES

growth of $100 · dividends reinvested · last 1y
IRD +294.6% (+294.6%/yr)YDES -40.9% (-40.9%/yr)IRD compounded faster over this window
Log scale — wide-divergence pair
101001kStart $1002026$395$59
IRD YDES

IRD vs YDES: by the numbers

  • •YDES is the larger company ($436M vs $362M market cap).
  • •Both run net losses; IRD's is the smaller (-1091.82% vs -1392.61% net margin).

Metrics side by side

Valuation

MetricIRDYDES
P/S ratio36.69N/A

Profitability

MetricIRDYDES
Gross margin99.87%-7.06%
Operating margin-271.90%-883.31%
Net margin-1091.82%-1392.61%
ROEN/A-66.49%
ROIC-59.29%N/A

Growth (annualized)

MetricIRDYDES
Revenue CAGR (5Y)150.49%N/A

Go deeper

Full IRD analysisFull YDES analysisInteractive comparison tool

Dig into the metrics

Opus Genetics ROEYD Bio Limited Ordinary Shares ROEOpus Genetics operating marginYD Bio Limited Ordinary Shares operating marginOpus Genetics revenue growthYD Bio Limited Ordinary Shares revenue growthOpus Genetics free cash flowYD Bio Limited Ordinary Shares free cash flow

Opus Genetics & YD Bio Limited Ordinary Shares appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.